Issue 12 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

25

No.

12

December 27, 2002Dec 27, 2002

Free

DOWNLOAD THE PDF

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

Arimidex Continues To Show Improvement Over Tamoxifen

Iressa May Benefit Some Breast Cancer, Studies Find

Gleevec Improves Survival Of CML In Accelerated Phase

Phase II Study Tests Chemo Plus Mylotarg For AML

“Proof Of Concept” Shown In Early Trial Of PKC-412

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

Clinical Trials Approved By NCI During November Are Listed

Recent Issues

Volume 50 | Issue 15 - April 12, 2024

Volume 50 | Issue 14 - April 05, 2024

Volume 50 | Issue 13 - March 29, 2024

Volume 50 | Issue 12 - March 22, 2024

Volume 50 | Issue 11 - March 15, 2024

Volume 50 | Issue 10 - March 08, 2024